Ishmeet S Juneja Joins Robins Appleby’s Litigation Group
Robins Appleby LLP is pleased to announce that Ishmeet S Juneja has joined the firm as an associate in our Litigation and Dispute Resolution Group.
September 15, 2026
Associate announcement
Smart & Biggar welcomes Tom Trinh to the Vancouver office as a Senior Associate in the Life Sciences practice group.
July 25, 2018
Smart & Biggar is pleased to announce that Tom Trinh has joined the firm as Senior Associate.
Tom Trinh is a results driven lawyer and strategic IP expert whose practice covers all aspects of procurement, commercialization and enforcement for life sciences.
Having held IP roles as in-house counsel in North America, Asia (specifically China and Japan) and Europe, Tom brings a global perspective to IP strategy and offers invaluable insight into the practical needs of corporate IP departments pursuing growth and business value.
Over the course of his fifteen-plus years as an in-house counsel in the pharmaceutical and consumer goods industries (including a major Fortune 500 company), Tom has led strategic IP procurement, commercialization and enforcement on behalf of his clients. His extensive experience allows his clients to trust his ability to anticipate their needs and provide timely, holistic and commercially relevant legal advice.
Tom is a member of Smart & Biggar’s Life Sciences practice group.
Smart & Biggar is widely recognized as Canada’s leading intellectual property firm. We are leaders in intellectual property and have been serving clients for over a century. Smart & Biggar operates as part of the IPH Limited group, under its own brand and independent from other IPH member firms.
View All Announcements by This Firm
Robins Appleby LLP is pleased to announce that Ishmeet S Juneja has joined the firm as an associate in our Litigation and Dispute Resolution Group.
September 15, 2026
Smart & Biggar is pleased to welcome Associate, Ashley Lam to our Patents practice group.
September 14, 2026
Smart & Biggar is pleased to welcome Associate, Michael Kovacevic to our Life Sciences practice group.
September 14, 2026